Are hospitals prescribing the more expensive remdesivir instead of cheaper alternatives?

Are hospitals prescribing the more expensive remdesivir instead of cheaper alternatives?

[ad_1]

So far in India, remdesivir has been launched by Hetero Labs and Cipla.

SynopsisThe DoP has asked the health ministry and drug regulatory authority to monitor if hospitals are prescribing the high-priced remdesivir where low-priced antibiotics would do, as it has received complaints of indiscriminate prescription of remdesivir by big hospitals, even in cases where it was not needed.

NEW DELHI: The Department of pharmaceuticals (DoP) has raised concerns over complaints of “indiscriminate” use of anti-viral drug remdesivir in hospitals which is resulting in shortage of the drug in

  • GIFT ARTICLE
  • FONT SIZE
  • SAVE
  • COMMENT

To Read the Full Story, Become an ET Prime Member

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Access the exclusive Economic Times stories, Editorial and Expert opinion

Already a Member?

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise



[ad_2]

Source link

Rate this post

leave your comment


Your email address will not be published. Required fields are marked *